A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study of a Non-Covalent, Reversible Bruton's Tyrosine Kinase Inhibitor, SNS 062, in Patients With B-Lymphoid Malignancies

UCI-16-95
NCT03037645
Cancer - Hodgkin's Lymphoma, Cancer - Leukemia, other, Cancer - Lymphoid Leukemia, Cancer - Multiple Myeloma, Cancer - Myeloid and Monocytic Leukemia, Cancer - Non-Hodgkin's Lymphoma, Cancer - Other Hematopoietic
Susan O'Brien
Open
Treatment
Ib/II
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.